First European Conference on SRS/SBRT and IG-IMRT Held in Milan

Sunnyvale, California (ots/PRNewswire) -

Accuray Incorporated [http://www.accuray.com ] , today announced
highlights from the First European Conference on stereotactic
radiosurgery/stereotactic body radiation therapy (SRS/SBRT) and
image-guided intensity-modulated radiation therapy (IG-IMRT), hosted
in partnership with the Istituto Europeo di Oncologia Milano and the
Universita degli studi di Milano, held in Milan, Italy on February
22-23, 2013.

The conference "Radiation Oncology: can we still treat without
image guidance?" was attended by more than 400 healthcare
professionals, including radiation oncologists, medical physicists
and hospital administrators from 32 countries. Outcomes of recent
research in areas such as central nervous system (CNS), head and
neck, breast, lung, gastrointestinal (GI), pelvis, total marrow
irradiation (TMI) and pediatrics were presented.

The independent Scientific Committee, led by Prof. Roberto
Orecchia (Istituto Europeo di Oncologia Milano, Italy) and Prof. Eric
Lartigau (Centre Oscar Lambret, Lille, France), focused on new
developments in the field and developed an educational event to
discuss the need of image guidance for a variety of clinical
indications in modern radiation therapy. "Daily image guidance is
crucial for all high-precision treatments, also for palliative
treatments" said Prof. Eric Lartigau.

"The TomoTherapy(R) System provides an automatic process that
makes our daily work easy" said Prof. Dirk Verellen, UZ Brussel.

Prof. Ben Heijmen, Erasmus MC-Daniel den Hoed Cancer Center of
Rotterdam, said "Additionally, dose to the healthy tissue can be
strongly reduced using optimal and numerous non-coplanar beams when
treating prostate cancer" comparing non-coplanar treatments to
coplanar treatments.

"There are non-adaptive and real-time adaptive solutions, but the
only solution that adapts for target motion in real-time, available
clinically, is the CyberKnife(R) System", added Dr. Iciar Santa
Olalla.

About Accuray

Accuray Incorporated , is a radiation oncology company that
develops, manufactures and sells personalized, innovative treatment
solutions that set the standard of care with the aim of helping
patients live longer, better lives. The Company's leading-edge
technologies deliver the full range of radiation therapy and
radiosurgery treatments.

Safe Harbor Statement Statements made in this press release that
are not statements of historical fact are forward-looking statements
and are subject to the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements
in this press release relate, but are not limited, to clinical
applications, clinical results, patient outcomes, and the Company's
leadership position in radiation oncology innovation. Forward-looking
statements are subject to risks and uncertainties that could cause
actual results to differ materially from expectations, including
risks detailed from time to time under the heading "Risk Factors" in
the company's report on Form 10-K filed on September 10, 2012, as
updated in our Form 10-Qs filed on November 8, 2012 & February 6,
2013, and as updated periodically by our other filings.
Forward-looking statements speak only as of the date the statements
are made and are based on information available to the Company at the
time those statements are made and/or management's good faith belief
as of that time with respect to future events. The Company assumes no
obligation to update forward-looking statements to reflect actual
performance or results, changes in assumptions or changes in other
factors affecting forward-looking information, except to the extent
required by applicable securities laws. Accordingly, investors should
not place undue reliance on any forward-looking statements.

Contacts

Anja Kleber
Marketing Director
Tel +33(0)1-55-23-20-20
akleber@accuray.com

Sophie Baumont
Edelman Paris
Tel +33(0)1-56-69-75-94
sophie.baumont@edelman.com

ots Originaltext: Accuray Europe
Im Internet recherchierbar: http://www.presseportal.de